Oncology
1 drug is in development for Angiosarcoma.
- Companies
- 1
- Clinical trials
- 7
BioSniper AIPage evidence connected
Prepared research question
Which programs lead the Angiosarcoma pipeline—and what evidence could change the picture?
Run cited research
Traceable citations · Unknowns marked
Drug Pipeline by Phase
Phase 3(1)
| Drug | Company |
|---|---|
| RP1 (vusolimogene oderparepvec) | Replimune Group, Inc. (REPL) |
About this indication
Angiosarcoma context
Oncology·MeSH: Hemangiosarcoma (D006394)
Also known as: Angiosarcomas, Hemangiosarcoma, Hemangiosarcomas
Frequently asked questions
How many drugs are in development for Angiosarcoma?
BioSniper tracks 1 drug in development for Angiosarcoma across 1 company.
How many clinical trials target Angiosarcoma?
There are 7 clinical trials targeting Angiosarcoma tracked by BioSniper.